127 related articles for article (PubMed ID: 28122354)
1. CX3CL1: a potential chemokine widely involved in the process spinal metastases.
Liu W; Bian C; Liang Y; Jiang L; Qian C; Dong J
Oncotarget; 2017 Feb; 8(9):15213-15219. PubMed ID: 28122354
[TBL] [Abstract][Full Text] [Related]
2. High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients.
Kehlen A; Greither T; Wach S; Nolte E; Kappler M; Bache M; Holzhausen HJ; Lautenschläger C; Göbel S; Würl P; Immel UD; Agaimy A; Wullich B; Taubert H
Int J Cancer; 2014 Nov; 135(9):2096-106. PubMed ID: 24676787
[TBL] [Abstract][Full Text] [Related]
3. Hypertrophy of the ligament flavum in degenerative lumbar stenosis associated with the increased expression of fractalkine (CX3CL1)/CX3CR1 chemokine.
Oh IS; Suh DW; Ha KY
Connect Tissue Res; 2013; 54(6):380-5. PubMed ID: 24060055
[TBL] [Abstract][Full Text] [Related]
4. CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway.
Liu P; Liang Y; Jiang L; Wang H; Wang S; Dong J
Int J Oncol; 2018 Oct; 53(4):1544-1556. PubMed ID: 30066854
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of expression level of CX3CL1-CX3CR1 axis in bone metastasis of lung cancer.
Liu Y; Ma H; Dong T; Yan Y; Sun L; Wang W
Clin Transl Oncol; 2021 Feb; 23(2):378-388. PubMed ID: 32638214
[TBL] [Abstract][Full Text] [Related]
6. ADAM17-regulated CX3CL1 expression produced by bone marrow endothelial cells promotes spinal metastasis from hepatocellular carcinoma.
Sun C; Hu A; Wang S; Tian B; Jiang L; Liang Y; Wang H; Dong J
Int J Oncol; 2020 Jul; 57(1):249-263. PubMed ID: 32319605
[TBL] [Abstract][Full Text] [Related]
7. Vertebral-specific activation of the CX3CL1/ICAM-1 signaling network mediates non-small-cell lung cancer spinal metastasis by engaging tumor cell-vertebral bone marrow endothelial cell interactions.
Wang K; Jiang L; Hu A; Sun C; Zhou L; Huang Y; Chen Q; Dong J; Zhou X; Zhang F
Theranostics; 2021; 11(10):4770-4789. PubMed ID: 33754027
[No Abstract] [Full Text] [Related]
8. Fractalkine/CX3CL1 in Neoplastic Processes.
Korbecki J; Simińska D; Kojder K; Grochans S; Gutowska I; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466280
[TBL] [Abstract][Full Text] [Related]
9. Expression of Chemokine XCL2 and CX3CL1 in Lung Cancer.
Zhou B; Xu H; Ni K; Ni X; Shen J
Med Sci Monit; 2016 May; 22():1560-5. PubMed ID: 27156946
[TBL] [Abstract][Full Text] [Related]
10. Expression of CX3CL1 and CCL28 in Spinal Metastases of Lung Adenocarcinoma and Their Correlation with Clinical Features and Prognosis.
Li S; Liu S; Xun J; Zhao F
J Healthc Eng; 2022; 2022():2580419. PubMed ID: 35494513
[TBL] [Abstract][Full Text] [Related]
11. The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas.
Li G; Hattermann K; Mentlein R; Mehdorn HM; Held-Feindt J
Oncol Rep; 2013 Feb; 29(2):563-70. PubMed ID: 23229614
[TBL] [Abstract][Full Text] [Related]
12. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules.
Butoi ED; Gan AM; Manduteanu I; Stan D; Calin M; Pirvulescu M; Koenen RR; Weber C; Simionescu M
Biochim Biophys Acta; 2011 Dec; 1813(12):2026-35. PubMed ID: 21888931
[TBL] [Abstract][Full Text] [Related]
13. The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells.
Nevo I; Sagi-Assif O; Meshel T; Ben-Baruch A; Jöhrer K; Greil R; Trejo LE; Kharenko O; Feinmesser M; Yron I; Witz IP
Cancer Lett; 2009 Jan; 273(1):127-39. PubMed ID: 18778890
[TBL] [Abstract][Full Text] [Related]
14. Vascular expression of the chemokine CX3CL1 promotes osteoclast recruitment and exacerbates bone resorption in an irradiated murine model.
Han KH; Ryu JW; Lim KE; Lee SH; Kim Y; Hwang CS; Choi JY; Han KO
Bone; 2014 Apr; 61():91-101. PubMed ID: 24401612
[TBL] [Abstract][Full Text] [Related]
15. CX3CL1 in the red bone marrow promotes renal cell carcinoma to metastasize to the spine by involving the Src-related pathway.
Hu AN; Chen FC; Wang KT; Wang ZQ; Liang Y; Dong J
Neoplasma; 2022 May; 69(3):670-679. PubMed ID: 35330998
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation.
Bjerkeli V; Damås JK; Fevang B; Holter JC; Aukrust P; Frøland SS
Rheumatology (Oxford); 2007 Sep; 46(9):1422-7. PubMed ID: 17616549
[TBL] [Abstract][Full Text] [Related]
17. Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1+ Immune Cells.
Kondo Y; Kimura O; Tanaka Y; Ninomiya M; Iwata T; Kogure T; Inoue J; Sugiyama M; Morosawa T; Fujisaka Y; Shimosegawa T
J Virol; 2015 Jul; 89(14):7016-27. PubMed ID: 25926643
[TBL] [Abstract][Full Text] [Related]
18. The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination.
Erreni M; Siddiqui I; Marelli G; Grizzi F; Bianchi P; Morone D; Marchesi F; Celesti G; Pesce S; Doni A; Rumio C; Roncalli MG; Laghi L; Mantovani A; Allavena P
J Immunol; 2016 Jan; 196(2):902-14. PubMed ID: 26673138
[TBL] [Abstract][Full Text] [Related]
19. Interaction between CX3CL1 and CX3CR1 regulates vasculitis induced by immune complex deposition.
Morimura S; Sugaya M; Sato S
Am J Pathol; 2013 May; 182(5):1640-7. PubMed ID: 23470165
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients.
Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
Int J Colorectal Dis; 2007 Oct; 22(10):1195-200. PubMed ID: 17611763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
